Skip to Content

Calcimar (calcitonin) Disease Interactions

There is 1 disease interaction with Calcimar (calcitonin):


Calcitonin (Includes Calcimar) ↔ mineral metabolism disorders

Severe Potential Hazard, Moderate plausibility. Applies to: Hypocalcemia, Vitamin D Deficiency

When calcitonin is used for the treatment of osteoporosis, hypocalcemia and other disturbances of mineral metabolism such as vitamin D deficiency should be treated prior to initiation of therapy. The desired increase in bone mineral density requires an adequate supply of calcium and vitamin D in the body. In patients with these conditions, serum calcium and symptoms of hypocalcemia should be monitored during therapy with calcitonin salmon nasal spray. Appropriate intake of calcium and vitamin D should be ensured throughout the course of treatment.


  1. "Product Information. Calcimar (calcitonin)." Rhone-Poulenc Rorer, Collegeville, PA.
  2. "Product Information. Miacalcin Injection, Synthetic (calcitonin)." Novartis Pharmaceuticals, East Hanover, NJ.

Calcimar (calcitonin) drug interactions

There are 6 drug interactions with Calcimar (calcitonin)

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.